The net proceeds of the offering will go toward the purchase of up to $850 million of CHS’ $1.78 billion in outstanding 8.875 percent senior notes due 2015. Previously, the tender cap for this offering was $700 million.
The sale of the notes is expected to close around March 21 and is expected to pay related fees and expenses and be used toward “general corporate purposes.”
More Articles on CHS:
CHS, West Tennessee Healthcare Settle Long-Term Antitrust Dispute
CHS Secures $1.5B in New Credit Facilities
CHS CEO Wayne Smith Elected Chair of Federation of American Hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
